Sign in

CIK 0001528115

  • Non-accelerated filer
  • Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
275414423
Phone
+1 650-822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale EVP & Chief Financial Officer sold 3,500 shares at $22.24 ($77,835)
  5. 4 Open-market sale President & CEO sold 7,602 shares at an average $28.11 ($213,662)
  6. 4 Open-market sale President & CEO sold 7,500 shares at an average $24.97 ($187,300)
  7. 4 Open-market sale EVP & Chief Scientific Officer sold 16,175 shares at an average $28.80 ($465,770)
  8. 4 Open-market sale EVP & Chief Medical Officer sold 3,995 shares at $30.17 ($120,512)
  9. 4 Open-market sale EVP & Chief Financial Officer sold 5,000 shares at an average $28.44 ($142,176)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy 10% owner bought 200,000 shares at $17.00 ($3,400,000)
  18. 4 Conversion 10% owner acquired 1,596,222 shares (conversion)
  19. 4 Open-market buy 10% owner bought 400,000 shares at $17.00 ($6,800,000)
  20. 4 Open-market buy EVP & Chief Financial Officer bought 2,000 shares at $17.00 ($34,000)

Page 9 of 11 · 206 filings